Biodesix, Inc. provided revenue guidance for the year 2022. The company anticipated generating between $37.5 million to $39.5 million in total revenue in 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +6.77% | +5.78% | -22.96% |
21/05 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
13/05 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.96% | 193M | |
-22.13% | 7.9B | |
+77.45% | 4.53B | |
+8.00% | 2.78B | |
-2.80% | 2.64B | |
-50.41% | 1.99B | |
-17.80% | 1.66B | |
-20.29% | 1.49B | |
+19.61% | 1.23B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2022